Computational Modeling Approaches in Search of Anti-Alzheimer's Disease Agents: Case Studies of Phosphodiesterase Inhibitors
Author:
Kumar Vinay,Roy Kunal
Reference109 articles.
1. Alzheimer’s Association (2021) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 17(3):327–406
2. Gauthier S, Rosa-Neto P, Morais JA, Webster C (2021) World Alzheimer Report 2021: journey through the diagnosis of dementia. Alzheimer’s Disease International, London
3. Tang Y, Zhang D, Gong X, Zheng J (2022) A mechanistic survey of Alzheimer’s disease. Biophys Chem 281:106735. https://doi.org/10.1016/j.bpc.2021.106735
4. Esang M, Gupta M (2021) Aducanumab as a novel treatment for Alzheimer’s disease: a decade of hope, controversies, and the future. Cureus 13(8):e17591. https://doi.org/10.7759/cureus.17591
5. Dutta BJ, Singh S, Seksaria S, Gupta GD, Bodakhe SH, Singh A (2022) Potential role of IP3/Ca2+ signaling and phosphodiesterases: relevance to neurodegeneration in Alzheimer’s disease and possible therapeutic strategies. Biochem Pharmacol 201:115071. https://doi.org/10.1016/j.bcp.2022.115071